Evidence map›Paper›PMID 34910520›Full record

ArticleScience advances2021

TGFBR3L is an inhibin B co-receptor that regulates female fertility.

Emilie Brûlé, Ying Wang, Yining Li, Yeu-Farn Lin, Xiang Zhou, Luisina Ongaro, Carlos A I Alonso, Evan R S Buddle, Alan L Schneyer, Chang-Hyeock Byeon and 13 more

Abstract read
In one paragraph

Article in Science advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Synthesis ofOrganic & biomolecular chemistry · 2023
    Article
  16. Review
  17. Article
  18. Article
  19. Evolving roles of activins and inhibins in ovarian cancer pathophysiology.American journal of physiology. Cell physiology · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Emilie BrûléDepartment of Anatomy and Cell Biology, McGill University, Montreal, Québec, Canada.ORCID 0000-0001-6149-6861
Ying WangDepartment of Pharmacology and Therapeutics, McGill University, Montreal, Québec, Canada.
Yining LiDepartment of Pharmacology and Therapeutics, McGill University, Montreal, Québec, Canada.ORCID 0000-0001-9131-1258
Yeu-Farn LinDepartment of Pharmacology and Therapeutics, McGill University, Montreal, Québec, Canada.
Xiang ZhouDepartment of Pharmacology and Therapeutics, McGill University, Montreal, Québec, Canada.
Luisina OngaroDepartment of Pharmacology and Therapeutics, McGill University, Montreal, Québec, Canada.
Carlos A I AlonsoDepartment of Pharmacology and Therapeutics, McGill University, Montreal, Québec, Canada.ORCID 0000-0002-9719-6542
Evan R S BuddleDepartment of Pharmacology and Therapeutics, McGill University, Montreal, Québec, Canada.
Alan L SchneyerFairbanks Pharmaceuticals, Concord, MA, USA.
Chang-Hyeock ByeonDepartment of Structural Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.ORCID 0000-0001-9997-7708
Cynthia S HinckDepartment of Structural Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.ORCID 0000-0002-2163-9378
Natalia MendelevDepartment of Neurology, Center for Advanced Research on Diagnostic Assays, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0001-8596-2986
John P RussellCentre for Craniofacial and Regenerative Biology, King's College London, London, UK.
Mitra CowanMcGill Integrated Core for Animal Modeling (MICAM), McGill University, Montreal, Québec, Canada.ORCID 0000-0003-1327-5233
Ulrich BoehmDepartment of Experimental Pharmacology, Center for Molecular Signaling, Saarland University School of Medicine, Homburg, Germany.ORCID 0000-0003-2436-6907
Frederique Ruf-ZamojskiDepartment of Neurology, Center for Advanced Research on Diagnostic Assays, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0002-2451-8598
Michel ZamojskiDepartment of Neurology, Center for Advanced Research on Diagnostic Assays, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0002-3699-089X
Cynthia L AndoniadouCentre for Craniofacial and Regenerative Biology, King's College London, London, UK.ORCID 0000-0003-4311-5855
Stuart C SealfonDepartment of Neurology, Center for Advanced Research on Diagnostic Assays, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0001-5791-1217
Craig A HarrisonDepartment of Physiology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.ORCID 0000-0003-1059-3682
Kelly L WaltonDepartment of Physiology, Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.ORCID 0000-0003-0627-2958
Andrew P HinckDepartment of Structural Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.ORCID 0000-0003-3320-8054
Daniel J BernardDepartment of Anatomy and Cell Biology, McGill University, Montreal, Québec, Canada.ORCID 0000-0001-5365-5586

Funding

MOLECULAR MECHANISM OF AGONISM AT THE GNRH RECEPTORR01DK046943 · NIDDK · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI STUART C. SEALFON · 1993 to 2026
$11.0M
LIGAND/RECEPTOR INTERACTIONS IN THE TGF BETA SUPERFAMILYR01GM058670 · NIGMS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI HINCK, ANDREW P · 1999 to 2017
$3.6M
Integrated systems biology of the pituitaryR56DK046943 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SEALFON, STUART C. · 2006 to 2024
$555k
Medical Research Council MR/T012153/1NIDDK NIH HHS R01 DK046943NIDDK NIH HHS R56 DK046943NIGMS NIH HHS R01 GM058670
6 · The paper itself

Abstract

Follicle-stimulating hormone (FSH), a key regulator of ovarian function, is often used in infertility treatment. Gonadal inhibins suppress FSH synthesis by pituitary gonadotrope cells. The TGFβ type III receptor, betaglycan, is required for inhibin A suppression of FSH. The inhibin B co-receptor was previously unknown. Here, we report that the gonadotrope-restricted transmembrane protein, TGFBR3L, is the elusive inhibin B co-receptor. TGFBR3L binds inhibin B but not other TGFβ family ligands. TGFBR3L knockdown or overexpression abrogates or confers inhibin B activity in cells. Female

Identifiers

PMID34910520
PMCPMC8673766

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.